These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18312822)

  • 1. Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.
    Munoz-Plaza CE; Strauss S; Astone-Twerell J; Jarlais DD; Gwadz M; Hagan H; Osborne A; Rosenblum A
    Int J Drug Policy; 2008 Feb; 19(1):71-8. PubMed ID: 18312822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
    Seeff LB; Hoofnagle JH
    Clin Liver Dis; 2003 Feb; 7(1):261-87. PubMed ID: 12691470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinfection with hepatitis C virus following sustained virological response in injection drug users.
    Grebely J; Knight E; Ngai T; Genoway KA; Raffa JD; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1281-4. PubMed ID: 20594256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care.
    Zeremski M; Zibbell JE; Martinez AD; Kritz S; Smith BD; Talal AH
    World J Gastroenterol; 2013 Nov; 19(44):7846-51. PubMed ID: 24307778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
    Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B
    Int J Drug Policy; 2007 Oct; 18(5):437-43. PubMed ID: 17854734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
    Grebely J; Petoumenos K; Matthews GV; Haber P; Marks P; Lloyd AR; Kaldor JM; Dore GJ; Hellard M;
    Drug Alcohol Depend; 2010 Mar; 107(2-3):244-9. PubMed ID: 19926405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
    Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
    Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injecting drug users' understanding of hepatitis C.
    O'Brien S; Day C; Black E; Dolan K
    Addict Behav; 2008 Dec; 33(12):1602-5. PubMed ID: 18762384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C treatment uptake and adherence among injecting drug users in the Czech Republic.
    Mravčík V; Strada L; Reimer J; Schulte B
    Epidemiol Mikrobiol Imunol; 2014 Nov; 63(4):265-9. PubMed ID: 25523218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection drug users' perceptions of drug treatment services and attitudes toward substitution therapy: a qualitative study in three Russian cities.
    Bobrova N; Alcorn R; Rhodes T; Rughnikov I; Neifeld E; Power R
    J Subst Abuse Treat; 2007 Dec; 33(4):373-8. PubMed ID: 17499960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.
    Strauss SM; Astone-Twerell J; Munoz-Plaza CE; Des Jarlais DC; Gwadz M; Hagan H; Osborne A; Rosenblum A
    BMC Health Serv Res; 2007 Mar; 7():39. PubMed ID: 17346346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
    Nguyen OK; Dore GJ; Kaldor JM; Hellard ME;
    Int J Drug Policy; 2007 Oct; 18(5):447-51. PubMed ID: 17854736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up.
    Dalgard O; Bjøro K; Hellum K; Myrvang B; Skaug K; Gutigard B; Bell H;
    Eur Addict Res; 2002 Jan; 8(1):45-9. PubMed ID: 11818693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.
    Swan D; Long J; Carr O; Flanagan J; Irish H; Keating S; Keaveney M; Lambert J; McCormick PA; McKiernan S; Moloney J; Perry N; Cullen W
    AIDS Patient Care STDS; 2010 Dec; 24(12):753-62. PubMed ID: 21138381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
    Zanini B; Lanzini A
    Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.
    Arain A; Robaeys G
    World J Gastroenterol; 2014 Sep; 20(36):12722-33. PubMed ID: 25278674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision tree.
    Ijioma SC; Pontinha VM; Holdford DA; Carroll NV
    J Manag Care Spec Pharm; 2021 Feb; 27(2):137-146. PubMed ID: 33506729
    [No Abstract]   [Full Text] [Related]  

  • 20. The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis.
    Treloar C; Rhodes T
    Qual Health Res; 2009 Sep; 19(9):1321-34. PubMed ID: 19690211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.